ChromaDex Corp (NAGE) - Company Projected Revenue

Corporate company logo of Chromadex Corp (NAGE)

The expected execution level of Chromadex Corp (NAGE) helps identify a trend reversal in time and avoid overpaying for the asset, while 0.04 serves as the current metric mark. Patents on cellular health and strict FDA oversight provide a defensive moat for the business. Revenues are generated through B2B supplies of Niagen and retail sales. Global demand for longevity components and anti-aging cosmetics ensures stable growth.

niagenbioscience.com - NAGE Projected Sales Volume (period 03/20/2025 - 11/16/2026)

Summary analytical data breakdowns for ChromaDex Corporation (NAGE)

- current price and projected stock value:
Summary company analytics:Chromadex Corp NAGE
Brand item of Niagen

The selection of defensive assets is based on a business's ability to maintain revenue during market shocks, which for Chromadex Corp (NAGE) is ensured by the uniqueness of its patents in cellular metabolism and protection against dumping. The projected sales volume measures expected cash flow, allowing an assessment of the business's fundamental stability through the company's planned sales dynamics and preventing entry into the asset at local price peaks.

Key competitors

Company Future Sales Volume ISRG (Intuitive Surgical)|DHR (Danaher Corp) - Company Future Revenue|BD - Company Future Sales Volume|Projected Sales Volume STERIS Group STE|WST - Company Projected Revenue|Baxter International (BAX) - Company Future Sales Volume|Masimo Corp (MASI) - Company Projected Revenue|Company Future Sales Volume Stevanato Group|Company Projected Revenue Teleflex Incorporated|Company Expected Sales Volume Merit Medical Corp MMSI|Company Projected Revenue Envista (NVST)|ICU Medical - Company Revenue Forecast|DENTSPLY SIRONA Inc. - Company Future Sales Volume|Company Projected Revenue Volume LMAT (LeMaitre Vascular Inc)|ATRC - Company Projected Revenue|Company Future Sales STAAR Surgical Co STAA|ZIMV (ZimVie Dental) - Company Future Sales Volume|angiodynamics.com (ANGO) - Projected Sales Volume|CERS (Cerus Inc) - Projected Sales Volume|Company Projected Revenue TKNO|Company Projected Revenue Monogram Technologies (MGRM)|Projected Sales Volume Sharps Technology Inc (STSS)|InfuSystem - Company Future Sales Volume|Company Future Revenue UTMD|KRMD: Company Future Sales Volume|NYXH - Projected Sales Volume|MBOT: Projected Sales Volume|Company Expected Sales Volume Pro-Dex, Inc. (PDEX)|Company Future Sales Volume ZTEK|ELUT: Company Future Revenue|Company Projected Revenue Milestone Scientific Corp (MLSS)|Company Future Sales NEXGEL Inc.|Company Projected Revenue Retractable Tech RVP|Harvard Bioscience - Company Projected Revenue|FEMY - Company Projected Revenue|meihuamed.com (MHUA) - Company Future Sales Volume|POAI (Predictive Oncology Corp) - Company Future Sales Volume|Callan JMB Inc. - Company Future Revenue|Company Projected Revenue atrioncorp.com|NURO: Company Future Revenue